{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:45:39Z","timestamp":1761093939130,"version":"build-2065373602"},"reference-count":19,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["annallergy.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Allergy, Asthma & Immunology"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.anai.2019.08.010","type":"journal-article","created":{"date-parts":[[2019,8,21]],"date-time":"2019-08-21T20:40:41Z","timestamp":1566420041000},"page":"440-443","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Sublingual immunotherapy and omalizumab cured allergic chronic rhinosinusitis and asthma: coincidence or synergistic effect?"],"prefix":"10.1016","volume":"123","author":[{"given":"George N.","family":"Konstantinou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisavet","family":"Kaitalidou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikolaos","family":"Skoulikaris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl 1","key":"10.1016\/j.anai.2019.08.010_bib1","first-page":"S3","article-title":"International Consensus Statement on Allergy and Rhinology: Rhinosinusitis","volume":"6","author":"Orlandi","year":"2016","journal-title":"Int Forum Allergy Rhinol"},{"key":"10.1016\/j.anai.2019.08.010_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4193\/Rhino12.000","article-title":"EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012: a summary for otorhinolaryngologists","volume":"50","author":"Fokkens","year":"2012","journal-title":"Rhinology"},{"key":"10.1016\/j.anai.2019.08.010_bib3","first-page":"S1","article-title":"Clinical practice guideline (update): adult sinusitis","volume":"152","author":"Rosenfeld","year":"2015","journal-title":"Otolaryngology"},{"key":"10.1016\/j.anai.2019.08.010_bib4","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.jaip.2016.04.012","article-title":"Chronic rhinosinusitis with nasal polyps","volume":"4","author":"Stevens","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.anai.2019.08.010_bib5","doi-asserted-by":"crossref","first-page":"129","DOI":"10.4193\/Rhino11.256","article-title":"Prevalence of chronic rhinosinusitis in Sao Paulo","volume":"50","author":"Pilan","year":"2012","journal-title":"Rhinology"},{"key":"10.1016\/j.anai.2019.08.010_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1081\/JAS-200044744","article-title":"Current thinking on the relationship between rhinosinusitis and asthma","volume":"42","author":"Jani","year":"2005","journal-title":"J\u00a0Asthma"},{"key":"10.1016\/j.anai.2019.08.010_bib7","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/alr.21674","article-title":"Prevalence of confirmed asthma varies in chronic rhinosinusitis subtypes","volume":"6","author":"Promsopa","year":"2016","journal-title":"Int Forum Allergy Rhinol"},{"key":"10.1016\/j.anai.2019.08.010_bib8","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1067\/mhn.2000.110961","article-title":"Chronic rhinosinusitis: allergy and sinus computed tomography relationships","volume":"123","author":"Emanuel","year":"2000","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.anai.2019.08.010_bib9","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.jaci.2006.01.011","article-title":"Asthma Control Test: reliability, validity, and responsiveness in patients not previously followed by asthma specialists","volume":"117","author":"Schatz","year":"2006","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2019.08.010_bib10","doi-asserted-by":"crossref","first-page":"120","DOI":"10.2500\/ajra.2012.26.3752","article-title":"Functional limitations and workdays lost associated with chronic rhinosinusitis and allergic rhinitis","volume":"26","author":"Bhattacharyya","year":"2012","journal-title":"Am J Rhinol Allergy"},{"key":"10.1016\/j.anai.2019.08.010_bib11","doi-asserted-by":"crossref","first-page":"134","DOI":"10.2500\/ajra.2016.30.4297","article-title":"Chronic rhinosinusitis: epidemiology and burden of disease","volume":"30","author":"DeConde","year":"2016","journal-title":"Am J Rhinol Allergy"},{"key":"10.1016\/j.anai.2019.08.010_bib12","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.jaci.2010.06.047","article-title":"Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 revision","volume":"126","author":"Brozek","year":"2010","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2019.08.010_bib13","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1111\/all.12638","article-title":"Clinical contraindications to allergen immunotherapy: an EAACI position paper","volume":"70","author":"Pitsios","year":"2015","journal-title":"Allergy"},{"key":"10.1016\/j.anai.2019.08.010_bib14","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1016\/j.jaip.2019.02.030","article-title":"IgE-mediated multimorbidities in allergic asthma and the potential for omalizumab therapy","volume":"7","author":"Humbert","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.anai.2019.08.010_bib15","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/all.12989","article-title":"Immunotherapy in allergic rhinitis and lower airway outcomes","volume":"72","author":"Cardona","year":"2017","journal-title":"Allergy"},{"key":"10.1016\/j.anai.2019.08.010_bib16","doi-asserted-by":"crossref","first-page":"145","DOI":"10.2500\/ajra.2014.28.4019","article-title":"Systematic review of immunotherapy for chronic rhinosinusitis","volume":"28","author":"DeYoung","year":"2014","journal-title":"Am J Rhinol Allergy"},{"key":"10.1016\/j.anai.2019.08.010_bib17","doi-asserted-by":"crossref","first-page":"42","DOI":"10.4193\/Rhin17.139","article-title":"Omalizumab treats chronic rhinosinusitis with nasal polyps and asthma together: a real life study","volume":"56","author":"Bidder","year":"2018","journal-title":"Rhinology"},{"key":"10.1016\/j.anai.2019.08.010_bib18","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1177\/0003489417731782","article-title":"Anti-IgE and anti-IL5 biologic therapy in the treatment of nasal polyposis: a systematic review and meta-analysis","volume":"126","author":"Rivero","year":"2017","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"10.1016\/j.anai.2019.08.010_bib19","doi-asserted-by":"crossref","first-page":"11","DOI":"10.4193\/Rhin17.156","article-title":"Monoclonal antibodies for the treatment of chronic rhinosinusitis with nasal polyposis: a systematic review","volume":"56","author":"Tsetsos","year":"2018","journal-title":"Rhinology"}],"container-title":["Annals of Allergy, Asthma & Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S108112061930599X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S108112061930599X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T13:22:59Z","timestamp":1761052979000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S108112061930599X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":19,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["S108112061930599X"],"URL":"https:\/\/doi.org\/10.1016\/j.anai.2019.08.010","relation":{},"ISSN":["1081-1206"],"issn-type":[{"type":"print","value":"1081-1206"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sublingual immunotherapy and omalizumab cured allergic chronic rhinosinusitis and asthma: coincidence or synergistic effect?","name":"articletitle","label":"Article Title"},{"value":"Annals of Allergy, Asthma & Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anai.2019.08.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}